ReviewExperimental biology and medicine (Maywood, N.J.)2019

Prohibitin: A hypothetical target for sex-based new therapeutics for metabolic and immune diseases.

Suresh Mishra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.